Celerion

Benefits of leveraging The Biosimilars Alliance:

The Biosimilars Alliance team members include experienced:

 

• Pharmacologists/Toxicologists
• Bioanalytical scientists
• Certified project managers
• Clinical pharmacologists and therapeutic area experts
• Former regulatory agency reviewers

Two global laboratories located in Europe (Zurich, Switzerland) and the USA (Lincoln, NE)

• Small and large molecule assays, biomarkers and immunogenicity tests
• Only CRO with global harmonized electronic laboratory notebook
• Technologies include: ELISA, RIA, ECLA, Luminex, LC-MS/MS

Global, GLP compliant preclinical laboratory in Lyon, France with more than 40 years of experience in Drug Safety Assessment

• Conducts more than 40% of business with biologics
• State of the art technologies for study performance and on-time reporting.
• Specialization in parenteral routes of administration

Four global clinical Phase I and IIa facilities located in Europe (Belfast, Northern Ireland, UK) and the USA (Lincoln, NE; Neptune, NJ; Phoenix, AZ)

• Over 730 beds (including 24 in-hospital) and conduct over 200 complete studies annually
• Executed over 6,000 Phase I studies conducted globally